SCHEMBL26107736

SCHEMBL26107736

C=CC(=O)N1CCN(c2nccnc2Nc2cccc(C(F)(F)F)c2)CC1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ EGFR P00533 3/20 0.52
▸ LMNA P02545 4/20 0.50
▸ MEN1 O00255 3/20 0.50
▸ KMT2A Q03164 3/20 0.50
▸ ALDH1A1 P00352 3/20 0.50
▸ GMNN O75496 1/20 0.50
▸ TTR P02766 1/20 0.50
▸ CYP1A2 P05177 1/20 0.50
▸ CYP3A4 P08684 1/20 0.50
▸ CYP2C9 P11712 1/20 0.50
▸ PKM P14618 1/20 0.50
▸ NFKB1 P19838 1/20 0.50
▸ UGT1A1 P22309 1/20 0.50
▸ PTGS1 P23219 1/20 0.50
▸ PTGS2 P35354 1/20 0.50
▸ PMP22 Q01453 1/20 0.50
▸ DHODH Q02127 1/20 0.50
▸ TEAD4 Q15561 1/20 0.50
▸ HIF1A Q16665 1/20 0.50
▸ GPR35 Q9HC97 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30591789 1.00 EGFR (0.52) EGFRLMNAMEN1KMT2AALDH1A1
SCHEMBL30591667 0.87 TRPV1 (0.53) EGFRTRPV1TRPA1
SCHEMBL26108175 0.87 TRPV1 (0.53) EGFRTRPV1TRPA1
SCHEMBL30591906 0.84 TRPV1 (0.49) EGFRPKMKDM4EPOLBTRPV1
SCHEMBL26134104 0.84 TRPV1 (0.49) EGFRPKMKDM4EPOLBTRPV1
SCHEMBL30591905 0.84 TRPV1 (0.49) EGFRPKMKDM4EPOLBTRPV1
SCHEMBL30591804 0.81 TRPV1 (0.41) EGFRMEN1KMT2AALDH1A1FGFR4
SCHEMBL30591849 0.81 TRPV1 (0.39) EGFRTRPV1
SCHEMBL30591895 0.81 SLC6A7 (0.51) EGFRLMNAMEN1KMT2AALDH1A1
SCHEMBL26107420 0.81 TRPV1 (0.41) EGFRMEN1KMT2AALDH1A1FGFR4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250206722-A1 SMALL MOLECULE INHIBITORS OF TEA DOMAIN FAMILY MEMBERS THE SCRIPPS RESEARCH INSTITUTE 2025-06-26 — — US claimed
WO-2023183768-A2 SMALL MOLECULE INHIBITORS OF TEA DOMAIN FAMILY MEMBERS THE SCRIPPS RESEARCH INSTITUTE (US) 2023-09-28 — — WO claimed
US-20250206722-A1 SMALL MOLECULE INHIBITORS OF TEA DOMAIN FAMILY MEMBERS THE SCRIPPS RESEARCH INSTITUTE 2025-06-26 — — US disclosed
WO-2023183768-A2 SMALL MOLECULE INHIBITORS OF TEA DOMAIN FAMILY MEMBERS THE SCRIPPS RESEARCH INSTITUTE (US) 2023-09-28 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250206722-A1 SMALL MOLECULE INHIBITORS OF TEA DOMAIN FAMILY MEMBERS YAP1, TEAD1, TEAD2 EGFR 789/4885LMNA 2257/4885MEN1 3200/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback